Fabio Perini Technology Enjoys Success at Tissue World São Paulo

echnological expertise was on display as Fabio Perini Brazil demonstrated its complete solution capabilities for the South American tissue converting market when Tissue World convened in Sao Paulo, Brazil. 

Constellation™, the company’s newest converting technology was displayed at the conference. Launched in June 2015, Constellation™ introduced a new era in tissue technology and has quickly become a success on a global scale: in just 18 months, over 50 lines have been sold throughout the five continents. Constellation™ is a solution that offers unprecedented winding quality and opportunities for product differentiation. Log growth during winding is managed by an innovative algorithm that characterizes Constellation™ technology, which result in greater control, quality and production efficiencies, previously unavailable in the industry.

Technology is not limited to Fabio Perini Brazil’s products as the company expands customer service capabilities with its Weareable remote support service. While technical support is always available to customers, reality makes it difficult to send a technician to every location regardless of distance in a timely manner. The Weareable technology changes this. All that is required is an Internet connection. The Weareable helmet uses bi-directional audio-visual capabilities, allowing a Fabio Perini Brazil technician to remotely examine the issue and offer a solution in real time. The innovative approach to addressing service issues demonstrates Fabio Perini Brazil’s commitment to superior technical support while actively pursuing solutions in keeping with Industry 4.0 technology.

Lastly, technology’s impact on the global tissue market is in the midst of a new era. Fabio Perini director of sales for South America, Dineo Silverio, delivered the conference’s keynote address: "The Global Tissue Market has Entered a New and Exciting Phase.".  Innovations such as Constellation™, remote wearables and other technology are changing the tissue converting industry. These will allow manufacturers to remain competitive on the shelf, decrease manufacturing costs while maintaining a positive customer experience and brand image. Silverio noted this paradigm shift began 20 months ago.